Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study.

HAIC TACE alternating therapy intermediate stage lenvatinib

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Jan 2021
Historique:
received: 30 11 2020
revised: 29 12 2020
accepted: 01 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 21 1 2021
Statut: epublish

Résumé

We aimed to evaluate the impact of alternating lenvatinib (LEN) and trans-arterial therapy (AT) in patients with intermediate-stage hepatocellular carcinoma (HCC) after propensity score matching (PSM). This retrospective study enrolled 113 patients with intermediate-stage HCC treated LEN. Patients were classified into the AT (

Identifiants

pubmed: 33466496
pii: cancers13010160
doi: 10.3390/cancers13010160
pmc: PMC7796435
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Am J Gastroenterol. 2008 Apr;103(4):914-21
pubmed: 18177453
Hepatol Commun. 2020 Jun 20;4(8):1218-1228
pubmed: 32766480
Hepatol Res. 2019 Aug;49(8):919-928
pubmed: 30969006
Liver Cancer. 2019 Oct;8(5):312-325
pubmed: 31768342
Liver Int. 2019 Sep;39(9):1704-1712
pubmed: 31319016
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Vasc Cell. 2014 Sep 06;6:18
pubmed: 25197551
Nat Rev Clin Oncol. 2018 Oct;15(10):599-616
pubmed: 30061739
Gut. 2020 Aug;69(8):1492-1501
pubmed: 31801872
Oncol Lett. 2020 Apr;19(4):2667-2676
pubmed: 32218817
World J Gastroenterol. 2004 Oct 1;10(19):2878-82
pubmed: 15334691
Lancet. 2018 Mar 31;391(10127):1301-1314
pubmed: 29307467
Liver Cancer. 2019 Mar;8(2):121-129
pubmed: 31019902
Hepatology. 2003 Feb;37(2):429-42
pubmed: 12540794
J Natl Cancer Inst. 2012 Apr 18;104(8):581-9
pubmed: 22457474
Cancer Chemother Pharmacol. 2016 Feb;77(2):243-50
pubmed: 26754678
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
Liver Cancer. 2016 Jul;5(3):190-7
pubmed: 27493894
JAMA Oncol. 2019 Jul 1;5(7):953-960
pubmed: 31070690
Hepatol Res. 2020 Jan;50(1):75-83
pubmed: 31660700
Acta Radiol. 2008 Jun;49(5):523-9
pubmed: 18568538
Cancers (Basel). 2020 Jul 11;12(7):
pubmed: 32664489
Oncology. 2020;98(11):787-797
pubmed: 32882687
Liver Cancer. 2020 Jun;9(3):245-260
pubmed: 32647629
Nat Commun. 2016 Sep 01;7:12680
pubmed: 27580750
Gastroenterology. 2006 Aug;131(2):461-9
pubmed: 16890600
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancers (Basel). 2019 Jul 31;11(8):
pubmed: 31370183

Auteurs

Shigeo Shimose (S)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Hideki Iwamoto (H)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
Department of Gastroenterology and Hepatology, Iwamoto Internal Medical Clinic, Kitakyusyu 802-0832, Japan.

Masatoshi Tanaka (M)

Department of Gastroenterology and Hepatology, Yokokura Hospital, Miyama, Fukuoka 839-0295, Japan.

Takashi Niizeki (T)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Tomotake Shirono (T)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Yu Noda (Y)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Naoki Kamachi (N)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Shusuke Okamura (S)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Masahito Nakano (M)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Hideya Suga (H)

Department of Gastroenterology and Hepatology, Yanagawa Hospital, Fukuoka 832-0077, Japan.

Taizo Yamaguchi (T)

Department of Gastroenterology and Hepatology, Iwamoto Internal Medical Clinic, Kitakyusyu 802-0832, Japan.

Takumi Kawaguchi (T)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Ryoko Kuromatsu (R)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Kazunori Noguchi (K)

Department of Gastroenterology and Hepatology, Omuta City Hospital, Fukuoka 836-8567, Japan.

Hironori Koga (H)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Takuji Torimura (T)

Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.

Classifications MeSH